Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00354484 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
A Phase 3 study, sponsored by American Regent.
- Completed
- Registry status
- Phase 3
- Development phase
- 291
- Enrollment target
NCT00354484: Completed Phase 3 study, sponsored by American Regent.
NCT00354484 is a Phase 3 study that has completed, run by American Regent. The registered enrollment target is 291 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00354484, a Phase 3 study, has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 291 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIT45 compared to the current standard of care in postpartum patients.
Interventions
- DRUG Ferric Carboxymaltose (FCM)
- DRUG Ferrous Sulfate tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
What the finished NCT00354484 record still lists
NCT00354484 is an interventional study that assigns participants to a tested intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which Ferric Carboxymaltose (FCM) is the first listed.
NCT00354484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00354484 about?
NCT00354484 is a clinical study titled "Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients". The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIT45 compared to the current standard of care in postpartum patients.
What is the current status of trial NCT00354484?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 291 participants. The study started on 2006-05. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00354484?
The interventions under investigation include: Ferric Carboxymaltose (FCM) (DRUG), Ferrous Sulfate tablets (DRUG).
Who is sponsoring clinical trial NCT00354484?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00354484's enrollment target sits among peer trials
291 1168th of 2000 higher than 830 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02074839 · 291 participants · Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- NCT03769766 · 291 participants · Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- NCT06563479 · 291 participants · Phase 3
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia